North Star Investment Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $700 | Hold |
11
| – | – | ﹤0.01% | 1146 |
|
|
2025
Q1 | $751 | Hold |
11
| – | – | ﹤0.01% | 1132 |
|
|
2024
Q4 | $696 | Sell |
11
-12
| -52% | -$759 | ﹤0.01% | 1165 |
|
|
2024
Q3 | $1.59K | Buy |
23
+1
| +5% | +$69 | ﹤0.01% | 1097 |
|
|
2024
Q2 | $1.49K | Hold |
22
| – | – | ﹤0.01% | 1063 |
|
|
2024
Q1 | $1.52K | Buy |
22
+1
| +5% | +$69 | ﹤0.01% | 1117 |
|
|
2023
Q4 | $1.38K | Hold |
21
| – | – | ﹤0.01% | 1084 |
|
|
2023
Q3 | $1.3K | Hold |
21
| – | – | ﹤0.01% | 1110 |
|
|
2023
Q2 | $1.32K | Hold |
21
| – | – | ﹤0.01% | 1115 |
|
|
2023
Q1 | $1.29K | Hold |
21
| – | – | ﹤0.01% | 1133 |
|
|
2022
Q4 | $1.36K | Hold |
21
| – | – | ﹤0.01% | 1128 |
|
|
2022
Q3 | $1K | Hold |
21
| – | – | ﹤0.01% | 1080 |
|
|
2022
Q2 | $1K | Hold |
21
| – | – | ﹤0.01% | 1085 |
|
|
2022
Q1 | $1K | Hold |
21
| – | – | ﹤0.01% | 1103 |
|
|
2021
Q4 | $1K | Hold |
21
| – | – | ﹤0.01% | 1130 |
|
|
2021
Q3 | $1K | Hold |
21
| – | – | ﹤0.01% | 1078 |
|
|
2021
Q2 | $1K | Hold |
21
| – | – | ﹤0.01% | 1055 |
|
|
2021
Q1 | $1K | Hold |
21
| – | – | ﹤0.01% | 1018 |
|
|
2020
Q4 | $1K | Hold |
21
| – | – | ﹤0.01% | 994 |
|
|
2020
Q3 | $1K | Buy |
+21
| New | +$1K | ﹤0.01% | 974 |
|
|
2016
Q1 | – | Sell |
-300
| Closed | -$16K | – | 767 |
|
|
2015
Q4 | $16K | Hold |
300
| – | – | ﹤0.01% | 527 |
|
|
2015
Q3 | $15K | Hold |
300
| – | – | ﹤0.01% | 536 |
|
|
2015
Q2 | $17K | Buy |
+300
| New | +$17K | ﹤0.01% | 517 |
|